You are here

For Journalists

Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.

Please contact:

Julie Langelier, Science Writer and Public Relations Specialist

Direct line: 415.734.5000

Megan McDevitt, Vice President of Communications
Direct line: 415.734.2019


 

Press Releases

September 21, 2017

A new center at Gladstone aims to find unforeseen uses for existing drugs

September 5, 2017

An unexpected collaboration leads to the discovery of an early predictor of IBD

August 24, 2017

A single drug could attack the virus on two fronts

August 2, 2017

The discovery could improve treatments for autoimmune diseases and cancer

July 20, 2017

Studer was selected for his groundbreaking research in stem cell–based therapies for Parkinson’s disease

July 12, 2017

E-Scape Bio, a Gladstone spin-off company, extends its Series A financing to generate novel therapies to treat neurodegenerative disorders

June 27, 2017

Researchers show that semen amyloids help the human body dispose of excess and defective sperm

June 6, 2017

Cells associated with seizures, schizophrenia, and ADHD found in the same region of the brain.

May 18, 2017

SAN FRANCISCO, CA—After decades of research aiming to understand how DNA is organized in human cells, scientists at the Gladstone Institutes have shed new light on this mysterious field by discovering how a key protein helps control gene organization.

May 17, 2017

SAN FRANCISCO, CA—A team of researchers at the Gladstone Institutes uncovered a new strategy to treat heart failure, a leading contributor to mortality and healthcare costs in the United States.

Pages